Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Brain Neoplasms
  • Glioblastoma
  • Neoplasm Proteins
  • PTEN Phosphohydrolase
  • Protein Kinase Inhibitors
  • Protein Kinases
  • Salvage Therapy
  • Sirolimus

abstract

  • http://www.ClinicalTrials.gov (#NCT00047073).

publication date

  • January 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2211560

Digital Object Identifier (DOI)

  • 10.1371/journal.pmed.0050008

PubMed ID

  • 18215105

Additional Document Info

start page

  • e8

volume

  • 5

number

  • 1